BARD1 Autoantibody Test Results for Ovarian Cancer Published
Filed with ASX · · 3 pages · English
Earlier from Inoviq
- Update on Legal Proceedings
- BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test
- BARD1 EXO-NET Exosome Data Presented at ISEV2021 Conference
- BARD1 Launches its RUO EXO-NET Product
- Appendix 4C and Quarterly Activities Report
Later from Inoviq
- BARD1 Investor Presentation
- BARD1 $15m Placement to Accelerate Cancer Diagnostic Program
- Updated Investor Presentation
- BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data
- BARD1 lodges spp and options prospectus
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq